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Abstract
Several studies have shown that cytotoxic T lymphocytes (CTLs) play an important role in controlling HIV/SIV infection.
Notably, the observation of escape mutants suggests a selective pressure induced by the CTL response. However, it remains
difficult to assess the definite role of the cellular immune response. We devise a computational model of HIV/SIV infection
having a broad cellular immune response targeting different viral epitopes. The CTL clones are stimulated by viral antigen
and interact with the virus population through cytotoxic killing of infected cells. Consequently, the virus population reacts
through the acquisition of CTL escape mutations. Our model provides realistic virus dynamics and describes several
experimental observations. We postulate that inter-clonal competition and immunodominance may be critical factors
determining the sequential emergence of escapes. We show that even though the total killing induced by the CTL response
can be high, escape rates against a single CTL clone are often slow and difficult to estimate from infrequent sequence
measurements. Finally, our simulations show that a higher degree of immunodominance leads to more frequent escape
with a reduced control of viral replication but a substantially impaired replicative capacity of the virus. This result suggests
two strategies for vaccine design: Vaccines inducing a broad CTL response should decrease the viral load, whereas vaccines
stimulating a narrow but dominant CTL response are likely to induce escape but may dramatically reduce the replicative
capacity of the virus.
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Introduction
HIV infection in humans and SIV infection in non-human
primates is not cleared by the host’s immune system. However,
there is partial control of virus replication that is mainly attributed
to the cytotoxic T lymphocyte (CTL) response [1,2]. Particularly
the evolution of immune escape mutations posing severe fitness
costs [3–9], suggests that there is a strong selective pressure
induced by the CTL response [10,11].
It is a challenge to acquire longitudinal data on CTL escape
since the virus diversity within a host has to be followed over a long
phase of chronic infection. Additionally, little data is available
during the early phase of infection, especially for HIV where the
infection is difficult to diagnose during the first weeks. Asquith et
al. [12] analyzed several data sets of immune escape in HIV, and
concluded that killing by the CTL response is inefficient in
infected humans. More recent studies described more rapid
immune escape of SIV, and estimated more efficient killing in non-
human primates [13–15]. Quantifying the process of CTL escape
and estimating rates remains problematic since the underlying
process of viral replication might be taken into account [16].
Furthermore, by analyzing escape at single epitopes it is difficult to
assess the strength of the total response of different CTL clones
recognizing different epitopes. Due to those difficulties it remains a
challenge to devise a realistic model of HIV/SIV dynamics and
the subsequent CTL escape.
The interaction of viral replication, mutation and selection by
different CTL responses appears to be complex. Studies have
observed CTL escape very early but also years after primary
infection [17–19]. Also, it has been shown that the number of
epitope-specific CTL responses varies over time [20–22]. Addi-
tionally, there is much controversy in the field of HIV evolution as
to whether stochastic effects play a role in viral evolution within a
host [23]. For example, it has been suggested that the waiting time
for compensatory mutations prolongs the emergence of escape
variants [24]. To better understand these processes, we present a
computational model of HIV/SIV infection taking into account
the dynamics of a broad cellular immune response targeting
different viral epitopes. The simulations allow us to follow the
dynamics in detail, and quantify several critical properties to
compare them to data.
Model
We develop a computational model of HIV/SIV virus dynamics
including a cellular immune response consisting of several CTL
clones (Fig. 1). We have n different CTL clones recognizing n
different epitopes derived from viral proteins. On the viral genome
we allow two mutations to occur per epitope. One mutation
confers escape from recognition by the specific CTL clone. Since
escape mutations may be associated with a fitness cost in viral
replication or infectivity, a second mutation can at least partially
compensate for the fitness loss.
We translate those interactions into a set of ordinary differential
equations (ODEs) and add stochastic events for viral mutation.
Classically, the processes of infecting target cells or the killing of
infected cells by CTLs have been described with simple mass-
action terms [25,26]. For instance, a previous study already
described antigenic escape from CTL clones during HIV-1
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infection with a simple mathematical model [27]. Recently, we
developed terms describing a density-dependent infection that
results in a better description of the dynamics of acute infection
(i.e. less oscillatory) of the viral load and the immune response
[28]. Moreover, the interaction of infected cells with effector
CTLs, both for proliferation of effector cells and the killing of
infected cells, were assumed to saturate according to Michaelis-
Menten kinetics. Here, we integrate those interaction terms to
devise a new virus dynamics model consisting of several CTL
clones that is described by the following differential equations:
dT
dt
~l{dT{
bT
Pm
i~1 Vifi
hbzTz
Pm
i~1 Ii
, ð1Þ
dIi
dt
~
bTVifi
hbzTz
Pm
j~1 Ij
{dI Ii
{kIi
Xn
j~1
Ejaij
hkz
Pm
l~1 Ilaljz
Pn
l~1 Elail
,
ð2Þ
dVi
dt
~pIi{dVVi, ð3Þ
dEi
dt
~szgEi
Xm
j~1
Ijaji
hgiz
Pn
l~1 Elajlz
Pm
l~1 Ilali
{dEEi: ð4Þ
Non-infected CD4+ target cells T are produced at a rate of l
cells per day, die at a rate dT and can become infected by virus
particles of type Vi with fitness fi at a maximal rate of b per day.
Target cell availability for virus particles is density dependent, as
the infection rate per virus particle is saturating over the total
number of CD4+ cells (non-infected and infected). After infection
of a target cell, reverse transcription occurs during which the virus
can mutate with a probability of m per position (for further details
see Methods). Having two positions to mutate per n epitopes, the
number of different viral variants, m, is maximally 22n. Infected
Figure 1. A Scheme of the Computational Model of HIV/SIV Infection. A number of n CTL clones can recognize n different epitopes and kill
the cells infected with virus expressing those epitopes. The virus population can evade recognition from specific CTL clones by acquiring escape
mutations (shown as e). Since escape mutations can be associated with a fitness cost in viral replication or infectivity, the virus additionally acquires
compensatory mutations (shown as c) that can partially restore the viral fitness.
doi:10.1371/journal.pcbi.1000103.g001
Author Summary
As a result of their high mutation rate, HIV and its
counterpart SIV in non-human primates can evade
recognition by the host immune response through the
generation of viral variants, the so-called escape mutants.
This avoidance of cytotoxic T lymphocyte (CTL) mediated
killing seems to be one of the major reasons why virus
replication is not controlled effectively. However, it
remains difficult to investigate the critical properties of
the dynamics of immune escape. To this end, we
developed a new computational model of HIV/SIV
infection consisting of several CTL clones that can
recognize specific parts of viral proteins, i.e., epitopes.
The simulations allow us to follow the dynamics of
immune escape in detail and help to interpret longitudinal
data of HIV/SIV infections. Interestingly, changing the
relative sizes of the CTL clones leads to a different
evolution of the virus. Instead of reducing the number of
infected cells, an alternative strategy of vaccine design
could be to reduce the replicative capacity of the virus that
might have implications for disease progression.
Immune Escape during HIV/SIV Infection
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cells Ii die at a rate of dI per day, and are cleared by those CTL
clones that can recognize an epitope on its surface. The matrix aij
defines the topology with which the CTL clone Ej recognizes
epitopes presented on the surface of the infected cell of type i, and
contains either 1 (recognition) or 0 (no recognition). Following
Michaelis-Menten kinetics, the CTL clones compete with each
other for clearance of infected cells (Fig. 2). WhenPm
l~1 Ilaljz
Pn
l~1 Elailwwhk, an infected cell is killed at a
maximal rate of k per day. With increasing hk, we approach mass-
action kinetics for the killing, i.e. whenPm
l~1 Ilaljz
Pn
l~1 Elailvvhk cells are killed at a per capita rate
of k
hk
Pn
j~1 Ejaij per day. Since the dynamics of virus particles Vi is
much faster than that of the cell populations [29], we assume a
quasi-steady-state for the virus particles and set Vi= pIi/dV [30].
‘Naive’ CTLs Ei are produced at a rate of s cells per day. If they
recognize antigen produced by Ij (i.e. aji=1) they proliferate at a
maximal rate g per day and die at a rate dE. Upon infection, virus
replicates rapidly and typically
Pm
l~1 Ilaljww
Pn
l~1 Elajl . There-
fore, CTL effector cells are produced at a half-maximal rate whenPm
l~1 Ilali~hgi . To account for different avidities for the different
CTL clones Ei we draw hgi from a uniform distribution. Once the
total number of CTL effector cells is high,
Pn
l~1 Elajl becomes
important and we get inter-clonal competition between the CTL
effector cells. An overview of the parameters is given in Table 1.
For a more detailed description of the model see Methods.
Results
Sequential Escape from Several CTL Clones
The most surprising phenomenon of CTL escape in HIV/SIV
is the time scale at which it occurs. Selection of escape variants has
been found to happen very early after acute infection, but also late
after years [17–19]. Additionally, it has been shown that escape
can occur sequentially [31]. Although it has been suggested that
compensatory mutations delay the appearance of escape variants,
it is still unclear why escape variants would occur so late when the
CTL clones recognizing the epitope have been present since acute
infection.
Our model describes the virus dynamics of anHIV/SIV infection
and the subsequent immune escape in a very realistic manner
(Fig. 3). Many escapes occur widely spaced out in time and we
observe that their appearance is determined by the dynamics of the
different CTL clones. Starting with the same CTL clone repertoire,
Fig. 3A represents a simulation where killing of infected cells
approaches mass-action dynamics (hk=10
12). Fig. 3B shows a
simulation where killing follows Michaelis-Menten kinetics and
CTL clones compete for killing of infected cells (hk=10
9). In both
simulations, the total number of infected cells peaks a few weeks
after infection and reaches a set-point level of around 107 to
108 cells (black line in top panels) [32]. The colored lines represent
the amount of virus-infected cells containing an escape mutation at
a specific epitope. Due to the large actual population size of infected
cells and the high mutation rate, all single escape and compensatory
mutants are produced rapidly during the acute phase of the
infection and are maintained in a mutation-selection balance. Some
escape variants are being selected early, and replace the wild-type
variant at this epitope (e.g., blue line). However, many escapes occur
late, despite their early presence in the virus population.
The dynamics of the CTL clones Ei are depicted in the bottom
panels. Upon infection, the clones become stimulated depending on
the parameter hgi defining their avidity, which generates a single or a
few dominant CTL clones and many sub-dominant clones. Escape
preferentially occurs from dominant clones that more efficiently kill
infected cells. However, due to a severe fitness cost for the escape
mutation, there is no escape from the most dominant CTL clone in
this particular simulation run. When an escape variant replaces the
wild-type variant, the CTL clone looses antigenic stimulation and
Figure 2. Killing Rate of an Infected Cell as a Function of the
Number of CTLs. For killing following mass-action dynamics, the
killing rate is linearly increasing with increasing number of CTLs
(straight line, hk= 10
12). However, if CTL clones compete with each
other to kill infected cells, a saturation effect occurs according to
Michaelis-Menten kinetics (dashed (hk=10
9) and dotted (hk= 10
8) line).
After a virus escapes recognition from a single CTL clone (blue arrow),
the killing of infected cells is reduced differently depending on these
functions (red arrows).
doi:10.1371/journal.pcbi.1000103.g002
Table 1. Parameters Used for Simulations of HIV/SIV
Infection.
Parameter Value Explanation and reference
b pdV{dI 1.5 d
21 Initial viral growth rate of 1.5 d21 [36].
g 1.0 d21 Maximal CTL proliferation rate [33].
l 26107 cells d21 Source of CD4+ target cells, tuned to obtain
an infected cell count between 107 and 10
8
during the chronic phase [32].
s
dE
103 cells Maintains a small number of 103 ‘naive’ cells
per CTL clone in absence of infection.
dT 0.01 d
21 Natural death rate of CD4+ target cells T.
dI 0.1 d
21 Virus-induced death rate of infected cells
(includes dT).
dE 0.01 d
21 Death rate of cytotoxic T lymphocytes
[41,42].
hgi [1.0, 5610
8] cells Uniform distribution of avidities for the CTL
clones. Generates a few dominant (low hgi )
and many sub-dominant (high hgi ) CTL
clones (see Fig. 6).
k 0:9 1z hkzI
E
 
d{1 Assumes a maximal death rate of infected
cells of 1.0 d21 [37] with CTLs accounting for
90% of infected cell death at the steady-state.
hk 10
8–1012 cells Allows killing of infected cells to follow
Michaelis-Menten kinetics (small hk) or to
approach mass-action dynamics (large hk).
m 361025 HIV-1 mutation rate per nucleotide [50].
n 20 Approximate number of epitopes that are
recognized by the CTL responses [21,40].
doi:10.1371/journal.pcbi.1000103.t001
Immune Escape during HIV/SIV Infection
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declines. Because of inter-specific competition between CTL clones,
previously sub-dominant clones can increase in size, increasing the
selection pressure for the epitopes they recognize.
It has been suggested that many escapes occur early, i.e. during
the decline phase in viral load after the peak of infection and that
they potentially prevent clearance of HIV/SIV. However, in our
simulations immune escape does not occur before the set-point
level is reached around two to three months after infection
(Fig. 4A). This is because the CTL clones only become effective
during the decline phase of virus after the peak of infection
[28,33]. Due to a transient CD4+ target cell depletion [34–36],
there is not enough viral replication for escape variants to increase
in frequency during this phase. Therefore, escape variants become
selected only after the set-point is approached. Nevertheless, many
escapes occur during the first months after set-point levels have
been attained. After about two years, the virus population
stabilizes as the ‘easy’ escapes have been done, the replicative
capacity is partially restored and only few escapes are expected to
appear later during infection. However, it is important to note that
Fig. 4A shows only the first appearance of escape variants. Some of
those variants will start to fluctuate in frequency or revert back to
wild-type and possibly re-emerge at a later time point. This has
implications for the analysis of longitudinal data. If an escape is
found to happen late it does not necessarily mean that it had not
been selected earlier during infection
Infected-cell death rates from different patients have been found
to be close to a normal distribution with a mean of 0.45 d21 [37].
We show that variation of the average infected-cell death rate is
also expected to occur within a patient due to the transient
decrease of the death rate during an immune escape from CTL
mediated killing (Fig. 4B and 4C). However, the death rate does
not necessarily decrease over time, i.e. the half-life of infected cells
is not expected to increase with disease progression.
Rates of Escape
Escape variants not only appear at different times during
infection but also with different rates. The rate at which an escape
variant replaces the wild-type, the so-called escape rate, is
determined by the balance between the evaded rate of killing
and the fitness cost of the escapemutation [12,38]. Furthermore, the
heterogeneity of the wild-type and the escape variant population at
all other epitopes can lead to a different selection induced by other
CTL clones. In general, we can define the escape rate as the ‘escape
variant growth rate - wild-type growth rate’. A recent study
quantified this process and concluded on the basis of slow escape
rates and minimal fitness costs that killing of HIV-1-infected cells is
inefficient in humans [12]. Unfortunately, the available data sets do
not allow us to follow the process of escape in detail. In contrast, our
model provides a unique tool to follow the dynamics and analyze
rates of escape and link those to rates of killing.
Fig. 5A shows the distribution of escape and the corresponding
rates that occur in 1000 simulation runs over five years of
infection. The histograms of killing and escape rates are shown in
Fig. 5B and 5C, respectively. Although the total killing by all CTL
clones is high (0.9 d21, see Table 1), most individual killing rates
are below 0.4 d21, and most escape rates are below 0.2 d21. The
lower rates of escape are due to the fitness cost of escape mutations
that cannot totally be restored by compensatory mutations.
Interestingly, the rates of escape are not distributed equally over
the time of infection (Fig. 5A). We therefore calculate the mean of
Figure 3. Immune Escape during the First Two Years after
Infection. In the top panels, the total number of infected cells (black
line) is shown together with the emerging escape mutants (colored
lines). Escape variants expressed as a frequency of the total viral
population are given in the middle panels. These variants can fluctuate
in frequency (e.g. red line) and, after dominating the viral population,
revert back to wild-type (e.g. green line). In the bottom panels, a
number of CTL clones proliferate upon infection (full and dashed lines)
but can slowly disappear after the virus population escapes recognition
(full colored lines). Starting with the same CTL repertoire, more escapes
occur when killing of infected cells approaches mass-action dynamics
(hk=10
12, shown in A) compared to Michaelis-Menten kinetics (hk= 10
9,
shown in B).
doi:10.1371/journal.pcbi.1000103.g003
Figure 4. Distribution of Immune Escape over the Course of
Infection. (A) Viral escapes over time given as an expected number of
escapes per month (average of 1000 simulations). It can be seen that
most escapes occur during the first year after infection (acute phase)
and fewer afterwords (chronic phase). The straight line shows the
replicative fitness of the viral population as an average over all
simulation runs (standard deviation is given by the gray area). The time
of escape is measured when an escape variant breaches a frequency of
50% of the total viral population for the first time. (B) Time-plot of
average infected-cell death rates during the chronic phase of infection.
The graph shows one simulation representing a single patient. (C)
Histogram of the death rates that are bound between 0.1 d21 and
1.0 d21. For (B) and (C), max hgi
 
~5|109 . For all figures, hk=10
12, i.e.
killing follows mass-action dynamics.
doi:10.1371/journal.pcbi.1000103.g004
Immune Escape during HIV/SIV Infection
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killing and escape rates per year after infection (Fig. 5D). It can be
seen that escape rates decrease late during infection and reach
relatively low values. The corresponding killing rates decrease after
the first year of infection and dramatically increase late during
infection. This result shows a) that the selection strength of CTL
clones can increase after there has been escape from other clones
and b) that escape against efficient CTL clones can be associated
with a dramatic cost in viral fitness that slows down the selection of
the escape variant.
In Fig. 5A–D we assumed mass-action kinetics for the
interaction of CTLs to kill infected cells, i.e., we set hk=10
12.
However, when CTL effector cells form a complex with infected
cells before delivering their lethal hit, the killing should follow
Michaelis-Menten kinetics [28,39]. We analyzed the influence of a
saturating killing term using several lower values of hk (Fig. 5E).
Although the maximal total killing is constant (see Table 1), we can
see that killing and escape rates decrease if the model approaches
Michaelis-Menten kinetics. Moreover, escape occurs relatively
frequent for high values of hk (mass-action) but rarely for low values
of hk (saturation) (black dots).
To estimate rates of escape from in vivo data one has to obtain ratios
of escape variants to the wild-type. However, a problem arises when
escapes are too rapid to be followed by the relatively long sampling
intervals [13]. This shortcoming can lead to an underestimation of
the rate of escape. To analyze this effect we measure the frequency of
an escape variant at four time points (100, 150, 200 and 250 days
after infection) and estimate the escape rate as described in reference
[12] (see alsoMethods). Fig. 5F shows the distribution of the estimated
escape rates (gray bars) and the true escape rates (black line). Even
though the sampling intervals were relatively short (50 days) it can be
clearly seen that the estimated rates are generally lower, with a mean
of about 50% of the true rates.
Our analysis shows several properties of the process of escape.
Even though the total killing induced by all CTL clones is high,
escape rates are expected to be slow. First, escape rates slow down
due to the acquired fitness cost in viral replication, especially
during later phases of infection. Secondly, if killing of infected cells
follows Michaelis-Menten kinetics, the rates of escape are
decreased. In addition, estimating rates of escape from ratios of
escape variants and wild-type virus is likely to lead to an
underestimation of the true rate. These findings highlight that
slow escape rates do not necessarily infer low killing rates.
Immunodominance and Viral Evolution
CTL responses during HIV infection generally consist of several
CTL clones recognizing many different epitopes. The size of those
CTL clones can differ substantially resulting in dominant and sub-
dominant responses [21,40]. In our model, the relative size of a
CTL clone depends on how well it can recognize viral antigen,
and is defined by hgi . By changing max hgi
 
we can change the
sizes of the CTL clones relative to each other. For high max hgi
 
we get strong immunodominance with a single or few dominant
clones and many sub-dominant clones, whereas low values of
max hgi
 
result in CTL clones that are very similar in size
(Fig. 6A). Note, that the total killing induced by the sum of all CTL
clones remains constant (0.9 d21) and is independent of max hgi
 
.
To investigate the effect of immunodominance we run
simulations for different values of max hgi
 
. Strong immunodo-
Figure 5. Rates of Killing and Escape. (A) The emergence of escape and the corresponding rates over a time course of 5 years of infection. (B)
Given those escapes, the distribution of killing rates given as an average frequency per simulation run. (C) The distribution of escape rates given as an
average frequency per simulation run. (D) Average killing and escape rates per year after infection. (E) The number of escapes during 5 years of
infection (filled circles) and the average rate of killing and escape as a function of hk (open symbols). (F) Estimated rates of escape by artificial virus
sampling. The two histograms show the distribution of the estimated (gray bars) and the true escape rates (black line). Mean of the estimated rates is
0.0960.08 d21 and the mean of the true rates is 0.1960.11 d21. All graphs represent data from 1000 simulation runs. The rates are measured when
the frequency of the escape variant is 50%. Means are given with standard errors since standard deviations are usually very large. hk= 10
12 if not
otherwise indicated.
doi:10.1371/journal.pcbi.1000103.g005
Immune Escape during HIV/SIV Infection
PLoS Computational Biology | www.ploscompbiol.org 5 July 2008 | Volume 4 | Issue 7 | e1000103
minance, where single CTL clones can induce a strong selection
pressure on the viral population, leads to more frequent escape
(Fig. 6B). Concurrently, viral replication is controlled less
efficiently and the number of infected cells increases with
increasing immunodominance (Fig. 6C). However, viral escape
can be associated with a fitness cost. Even though the number of
infected cells increases, the replicative capacity of the viral
population is reduced substantially (Fig. 6D).
Discussion
The interaction of the HIV quasispecies with the CTL response
appears to be complex which makes the analysis of experimental
data difficult. Mathematical and computational models have been
helpful to investigate how different processes influence each other.
For example, a previous model described how shifting immuno-
dominance and antigenic oscillations can occur during HIV
infection [27]. Now, with a model incorporating multiple CTL
responses together with escape and compensatory mutations, we
show that the dynamics of the CTL clones are sufficient to explain
the sequential and late occurrence of escape variants. Upon loss of
antigenic stimulation, CTL clones disappear slowly [41,42].
Concomitantly, other CTL clones can increase in size and induce
more efficient killing that leads to further escape that is
sequentially distributed over many years after infection. Interest-
ingly, the outgrowth of escape variants does not occur earlier even
though they are always present in the viral population. It has been
suggested that a small effective population size of HIV-infected
cells is responsible for the late production and selection of escape
variants [43]. However, a recent study argues that stochastic
effects play a minor role for the appearance of deleterious and
beneficial mutations in HIV [23]. Also, our simulations show that
viral evolution is fairly deterministic. The model allows us to
simulate two identical ‘patients’ that are infected with the same
virus and have the same CTL repertoire. In that case, the
stochastic generation of the viral variants results in a slow increase
in variation over years (results not shown). For example, the
emergence of a certain escape variant is predictable during the first
years after infection but becomes more variable later on. This is in
line with a recent study where concordant evolution of HIV has
been observed in mono-zygotic twins early during infection but
more variation has been shown at later stages of the infection [21].
Another explanation for the late appearance of escape variants
that has been put forward is the waiting time for compensatory
mutations [24]. Our simulations show that single compensatory
mutations are expected to be present in the viral quasispecies and
therefore should not slow down the emergence of escape. However,
if more compensatory mutations are needed to restore the fitness
loss of an escape variant they can delay their occurrence (results not
shown). Due to epistasis however, the fitness interactions of several
mutations are highly complex and therefore simulation results
depend mainly on a presumed fitness landscape. Therefore, we
propose a way to test the two hypotheses for the late appearance of
escape variants. First, if the delay was due to the waiting time for
compensatory mutations, late escapes would be associated with
more compensatory mutations than early escapes. If on the other
hand, the dynamics of CTL clones mainly determines the late
appearance, CTL clones where escape has been detected late
should have increased in size relative to the other CTL clones in the
period before. Both of these hypotheses can be tested by analyzing
longitudinal data of HIV/SIV infections.
Our simulations proved to be useful to analyze the process of
escape. We conclude that, although killing can be very efficient,
escape rates are expected to be low. The association with a fitness
cost and the way how CTL clones interact with infected cells
critically influence the rates of escape. Hence, it appears to be
important to study those interactions to derive realistic killing
terms [39]. Furthermore, we have shown that estimating rates of
escape is difficult from infrequent sequence measurements. We
propose that sequence intervals should be shortened to follow the
outgrowth of the variants. Additionally, there might be other
reasons that slow down the selection of escape variants. For
example, our model does not take into account multiple infected
cells. As the fraction of multiple infected cells is large [44], escape
variants are likely to appear in cells that are also infected with wild-
type virus. As long as wild-type epitopes are presented on the cells
surface, the escape variant does not gain any growth advantage
compared to the wild-type. As a consequence, the selection of
escape variants is expected to slow down.
Immunodominance affects the viral evolution within a host. A
higher degree of immunodominance leads to more frequent escape
Figure 6. Influence of Immunodominance on Viral Evolution.
(A) The distribution of CTL clones plotted as a function of max hgi
 
.
Lower values ofmax hgi
 
yield a broad repertoire of CTL clones that are
similar in size whereas for higher max hgi
 
the degree of immunodo-
minance increases. The dots represent the size of CTL clones for 10
simulations at 50 days after infection. Noise is added on the horizontal
axis for better visibility. (B) Escape is more frequent for a higher degree
of immunodominance. The numbers of escape variants that have
occurred within 5 years of infection are shown as circles. As many
escapes start to oscillate or revert back to wild-type, the number of
escapes that are above 50% in frequency at 5 years after infection is
shown as squares. (C) Infected cell numbers increase with increasing
immunodominance. (D) The replicative fitness of the virus decreases
with increasing immunodominance. Numbers are given after 5 years of
infection and represent averages from 1000 simulation runs.
doi:10.1371/journal.pcbi.1000103.g006
Immune Escape during HIV/SIV Infection
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with a reduced control of viral replication but a substantially
impaired replicative capacity of the virus. This is interesting as
vaccines generally aim to induce a broad CTL response where
escape is unlikely to occur. However, a dramatic reduction of the
replicative capacity of the virus due to escape could indeed slow
down disease progression and/or reduce transmission [45]. Based
on these results we identify two strategies for vaccine design:
Vaccines inducing a broad CTL response should decrease the viral
load whereas vaccines stimulating a narrow but dominant CTL
response are likely to induce escape and consequently reduce the
replicative capacity of the virus.
The balance between the CTL response and the viral
population acquiring escape mutations appears to be a dynamical
process over a long period of infection. We have shown that it is
important to analyze the kinetics of this process and also the time
scale (acute and chronic phase) at which it occurs. More
longitudinal data of HIV infections will help to further investigate
this process and future research is likely to go into this direction.
Methods
Stochastic Events
The set of ordinary differential equations (ODEs) is extended
with stochastic events for viral mutation (similar as in [46]).
Initially at day 0, infection occurs with the wild-type. Therefore
the number of viral variants, m(0), is 1. In the following, the ODEs
are integrated using the routine odeint from Numerical Recipes
[47]. Every time step Dt=1 day, we approximate the number of
cells that have been infected with virus of type i during the last
time step according to
DIi tð Þ~ bT tð ÞVi tð Þfi
hbzT tð Þz
Pm
j~1 Ij tð Þ
Dt: ð5Þ
After infection, reverse transcription of the viral RNA occurs
during which every position can mutate with the probability m. For
the cells being newly infected with virus of type i, we calculate the
integer number xij of cells where the virus mutated into another
type j. This is done by drawing from the binomial distribution
xij=B(DIi, m) for each of the two positions (escape and
compensatory) over a total of n epitopes. Then, the infected cell
populations are updated accordingly (i.e. Ii = Ii2xij and Ij = Ij+xij).
Whenever a previously not existing viral variant j is generated,
m(t) =m(t2Dt)+1, and the set of ODEs is expanded. We also take
into account the actual population size of virus infected cells [23].
If the number of infected cells of a certain variant falls below 1, the
variant is deleted. Note, that in order for the simulations to be
computationally efficient, we only generate the viral variants
stochastically but do not include possible fluctuations at small
population sizes. However, this hybrid stochastic-deterministic
approach is sufficient to keep the variants in a mutation-selection
balance. Running the model using the Gillespie algorithm [48], we
observed that whenever the different viral variants become
selected, their growth approximates the deterministic description
from the ODEs. A program of the model was written in C and
simulations were run under Linux. The source code can be
obtained freely on request from the authors.
Viral Fitness
Escape mutations in HIV and SIV are likely to confer a fitness
cost in viral replication or infectivity [3–9]. A recent study by
Parera et al. [49] showed that fitness effects caused by random
single mutations are approximately uniformly distributed. There-
fore, we draw the fitness of a virus containing a single mutation
relative to the wild-type virus from a uniform distribution between
0.0 and 1.0. However, the combined effect of an escape mutation
together with a compensatory mutation in a single epitope confers
a higher fitness that is drawn uniformly between wild-type fitness
(fwt=1.0) and the higher fitness of the two single variants.
Estimating Rates of Escape
The outgrowth of an escape variant and the subsequent
replacement of the wild-type can be considered as a competitive
growth between two populations:
dw
dt
~aw{bw{cw, ð6Þ
de
dt
~a0e{be, ð7Þ
where w is the wild-type and e is the escape variant. Cells infected
with wild-type virus replicate at a net rate a and are killed by all
CTL clones recognizing epitopes other than the escape epitope at
rate b. The CTL clone recognizing the escape epitope kills wild-
type cells at rate c. Cells infected with the escape variant replicate
at a net rate a9 and are only killed by the CTL clones recognizing
epitopes other than the escape epitope. For c.0, the escape
variant gains a growth advantage as long as the fitness cost of the
escape, d= a2a9, is not higher (i.e. d,c). As shown in Asquith et al.
[12] this model can be fitted to longitudinal data of escape. This is
done using the routine lmfit (http://sourceforge.net/projects/
lmfit) based on the Levenberg-Marquardt algorithm to solve
nonlinear least-squares problems. However, the fitting is likely to
underestimate the true rates of escape as it is illustrated in Fig. 7.
Killing Terms
We assume Michaelis-Menten kinetics for the killing of infected
cells by CTL effector cells:
kIi
Xn
j~1
Ejaij
hkz
Pm
l~1 Ilaljz
Pn
l~1 Elail
: ð8Þ
This term takes into account the effector/target cell ratio of the
cellular interaction: the total killing is proportional to infected cells
at high effector cell densities and proportional to effector cells at
high infected cell densities [28]. However, we also analyzed the
Figure 7. Estimating Rates of Escape. (A) Escape variants often only
transiently replace the wild-type variant and oscillate thereafter.
Sequence measurements are taken at arbitrary time points (squares).
(B) When a model is fitted to those data points the initial escape rate is
likely to be underestimated.
doi:10.1371/journal.pcbi.1000103.g007
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outcome of other killing terms following different kinetics:
kIi
Xn
j~1
Ejaij : ð9Þ
Here, infected cells are killed by effector cells following simple
mass-action kinetics. We mentioned that by increasing hk in
Equation 8 we approach mass-action kinetics and the results are
discussed.
kIi
Pn
j~1 Ejaij
hkz
Pn
j~1 Ejaij
: ð10Þ
Single saturation over CTL effector cells E is similar to the double-
saturating term used in Equation 8: once the set-point is reached,Pn
l~1 Elailww
Pm
l~1 Ilalj , and Equation 8 approaches
Equation 10.
kIi
Xn
j~1
Ejaij
hkz
Pm
l~1 Ilaij
: ð11Þ
Taking into account that CTL effector cells need some time to
interact with infected cells before delivering their lethal hit, a
saturation effect occurs as given in Equation 11 (see also reference
[28]). We define k~
0:9 hkzIð Þ
E , to have infected cells being killed at
a maximal rate of 0.9 d21 during the chronic phase of infection. I*
and E* are the numbers of infected cells and CTL effector cells,
respectively, in the steady-state in absence of escape. During the
acute phase, we observe three types of dynamics: 1) For
hk,5610
7, the infection is always cleared since an infected cell
can be killed at a rate of k E
I
per day that can be enormous. 2) For
56107,hk,7610
7, a very rapid escape during acute infection can
prevent clearance of the infection. 3) For hk.7610
7, we approach
mass-action kinetics since hk..I and the term becomes
k
hk
IE.
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